Reiss, K. A., Yu, S., Mamtani, R., Mehta, R., D’Addeo, K., Wileyto, E. P., . . . Kaplan, D. E. (2017). Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study. J Clin Oncol.
Citação norma ChicagoReiss, Kim A., Shun Yu, Ronac Mamtani, Rajni Mehta, Kathryn D’Addeo, E. Paul Wileyto, Tamar H. Taddei, and David E. Kaplan. "Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study." J Clin Oncol 2017.
ציטוט MLAReiss, Kim A., et al. "Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study." J Clin Oncol 2017.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.